Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir

[1]  T. Brown,et al.  Metabolic abnormalities in HIV-infected patients: An update , 2006, Current infectious disease reports.

[2]  P. Hruz.  Molecular Mechanisms for Altered Glucose Homeostasis in HIV Infection. , 2006, American journal of infectious diseases.

[3]  Ling Yang,et al.  Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Jonathan R Lindner,et al.  Mixed meal and light exercise each recruit muscle capillaries in healthy humans. , 2006, American journal of physiology. Endocrinology and metabolism.

[5]  J. Klaunig,et al.  Indinavir impairs endothelial function in healthy HIV-negative men. , 2005, American heart journal.

[6]  R. Bressler.  Herb-drug interactions: interactions between ginseng and prescription medications. , 2005, Geriatrics.

[7]  Stephen R Cole,et al.  Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. , 2005, Archives of internal medicine.

[8]  S. Gardner,et al.  Clinical Assessment of Effects of Botanical Supplementation on Cytochrome P450 Phenotypes in the Elderly , 2005, Drugs & aging.

[9]  C. Yuan,et al.  Ginseng and diabetes. , 2005, The American journal of Chinese medicine.

[10]  T. Karrison,et al.  Brief Communication: American Ginseng Reduces Warfarin's Effect in Healthy Patients , 2004, Annals of Internal Medicine.

[11]  A. Mitra,et al.  In Vitro Interaction of the HIV Protease Inhibitor Ritonavir with Herbal Constituents: Changes in P-gp and CYP3A4 Activity , 2004, American journal of therapeutics.

[12]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[13]  R. Kim,et al.  Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. , 2003, Pharmacogenetics.

[14]  F. Achike,et al.  Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway , 2003, Clinical and experimental pharmacology & physiology.

[15]  E. Barrett,et al.  Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. , 2003, American journal of physiology. Endocrinology and metabolism.

[16]  G. Anderson,et al.  Drug Interaction Potential of Soy Extract and Panax Ginseng , 2003, Journal of clinical pharmacology.

[17]  J. Donovan,et al.  Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[18]  S. Walmsley,et al.  Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. , 2003, AIDS patient care and STDs.

[19]  Lawrence A Leiter,et al.  Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia , 2003, European Journal of Clinical Nutrition.

[20]  Ji An Wu,et al.  Anti-hyperglycemic effects of ginseng: comparison between root and berry. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[21]  S. Gardner,et al.  Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans , 2002, Clinical pharmacology and therapeutics.

[22]  K. Polonsky,et al.  Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. , 2002, Diabetes.

[23]  M. Schambelan,et al.  Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study , 2002, AIDS.

[24]  J. Falloon,et al.  The effect of garlic supplements on the pharmacokinetics of saquinavir. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  M. Harkey,et al.  Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[26]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[27]  K. M. Lin,et al.  An open trial of nifedipine-herb interactions Nifedipine with St Johns wort, Ginseng or Ginkgo biloba , 2001 .

[28]  Lawrence A Leiter,et al.  Konjac-Mannan and American Ginsing: Emerging Alternative Therapies for Type 2 Diabetes Mellitus , 2001, Journal of the American College of Nutrition.

[29]  S. Chung,et al.  Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice , 2001, Archives of pharmacal research.

[30]  M. Schambelan,et al.  Metabolic effects of indinavir in healthy HIV-seronegative men , 2001, AIDS.

[31]  L. Standish,et al.  Alternative medicine use in HIV-positive men and women: Demographics, utilization patterns and health status , 2001, AIDS care.

[32]  Lawrence A Leiter,et al.  American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. , 2001, The American journal of clinical nutrition.

[33]  R. D'Agostino,et al.  Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Pre-publication history , 2001 .

[35]  Lawrence A Leiter,et al.  Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. , 2000, Diabetes care.

[36]  J. Falloon,et al.  Indinavir concentrations and St John's wort , 2000, The Lancet.

[37]  C. Yuan,et al.  Ginseng pharmacology: multiple constituents and multiple actions. , 1999, Biochemical pharmacology.

[38]  M. Gershwin,et al.  Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.

[39]  C. N. Gillis,et al.  Panax ginseng pharmacology: a nitric oxide link? , 1997, Biochemical pharmacology.

[40]  Andrew Carr,et al.  HIV protease inhibitors , 1996, AIDS.

[41]  S. Sheu,et al.  A comparative study on commercial samples of ginseng radix. , 1995, Planta medica.

[42]  A. Rautio,et al.  Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight , 1995, Diabetes Care.

[43]  S B Heymsfield,et al.  Statistical considerations regarding the use of ratios to adjust data. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[44]  P. Eckman,et al.  The essential book of traditional Chinese medicine , 1988 .

[45]  M. Yasuda,et al.  Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. , 1982, Journal of pharmacobio-dynamics.

[46]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[47]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.